TABLE OF CONTENTS
Volume 24, Issue 29 (7 July 2005)
Original Papers
HDAC inhibitors enhance the apoptosis-inducing potential of TRAIL in breast carcinoma
Thiyam Ramsing Singh, Sharmila Shankar and Rakesh K Srivastava
Oncogene 24: 4609-4623; advance online publication, May 16, 2005; doi:10.1038/sj.onc.1208585
IL-2- and STAT5-regulated cytokine gene expression in cells expressing the Tax protein of HTLV-1
Michelle M Fung, Yen-Lin Chu, J Lynn Fink, Anne Wallace and Kathleen L McGuire
Oncogene 24: 4624-4633; advance online publication, February 28, 2005; doi:10.1038/sj.onc.1208507
Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications
Lizzia Raffaghello, Ignazia Prigione, Paola Bocca, Fabio Morandi, Marta Camoriano, Claudio Gambini, Xinhui Wang, Soldano Ferrone and Vito Pistoia
Oncogene 24: 4634-4644; advance online publication, May 9, 2005; doi:10.1038/sj.onc.1208594
Epigenetic mechanisms affect mutant p53 transgene expression in WAP-mutp53 transgenic mice
Frauke Krepulat, Jürgen Löhler, Christina Heinlein, Andrea Hermannstädter, Genrich V Tolstonog and Wolfgang Deppert
Oncogene 24: 4645-4659; advance online publication, May 2, 2005; doi:10.1038/sj.onc.1208557
Identification of molecular apocrine breast tumours by microarray analysis
Pierre Farmer, Herve Bonnefoi, Veronique Becette, Michele Tubiana-Hulin, Pierre Fumoleau, Denis Larsimont, Gaetan MacGrogan, Jonas Bergh, David Cameron, Darlene Goldstein, Stephan Duss, Anne-Laure Nicoulaz, Cathrin Brisken, Maryse Fiche, Mauro Delorenzi and Richard Iggo
Oncogene 24: 4660-4671; advance online publication, May 9, 2005; doi:10.1038/sj.onc.1208561
Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling
Véronique Ouellet, Diane M Provencher, Christine M Maugard, Cécile Le Page, Fengge Ren, Christian Lussier, Jaroslav Novak, Bing Ge, Thomas J Hudson, Patricia N Tonin and Anne-Marie Mes-Masson
Oncogene 24: 4672-4687; advance online publication, May 30, 2005; doi:10.1038/sj.onc.1208214
Multimodality expression profiling shows SEPT9 to be overexpressed in a wide range of human tumours
Michael Scott, Paula L Hyland, Gordon McGregor, Kenneth J Hillan, S E Hilary Russell and Peter A Hall
Oncogene 24: 4688-4700; advance online publication, March 14, 2005; doi:10.1038/sj.onc.1208574
Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors
Jiazhi Sun, De-an Wang, Rishi K Jain, Adam Carie, Steve Paquette, Eileen Ennis, Michelle A Blaskovich, Laura Baldini, Domenico Coppola, Andrew D Hamilton and Saïd M Sebti
Oncogene 24: 4701-4709; advance online publication, May 16, 2005; doi:10.1038/sj.onc.1208391
Interaction of human Thy-1 (CD 90) with the integrin 
v
3 (CD51/CD61): an important mechanism mediating melanoma cell adhesion to activated endothelium
Anja Saalbach, Anne Wetzel, Uwe-Frithjof Haustein, Michael Sticherling, Jan C Simon and Ulf Anderegg
Oncogene 24: 4710-4720; advance online publication, May 16, 2005; doi:10.1038/sj.onc.1208559
Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer
Naoyuki Umetani, Takuji Mori, Kazuo Koyanagi, Masaru Shinozaki, Joseph Kim, Armando E Giuliano and Dave S B Hoon
Oncogene 24: 4721-4727; advance online publication, May 9, 2005; doi:10.1038/sj.onc.1208538
Interaction and colocalization of Rad9/Rad1/Hus1 checkpoint complex with replication protein A in human cells
Xiaoming Wu, Steven M Shell and Yue Zou
Oncogene 24: 4728-4735; advance online publication, May 9, 2005; doi:10.1038/sj.onc.1208674
Short Report
A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model
Noreen Majeed, Marie-José Blouin, Paula J Kaplan-Lefko, Jane Barry-Shaw, Norman M Greenberg, Pierrette Gaudreau, Tarek A Bismar and Michael Pollak
Oncogene 24: 4736-4740; advance online publication, May 2, 2005; doi:10.1038/sj.onc.1208572
